$5190
$4152
The ELISA diagnostic test market size is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Advancements in ELISA-based procedures resulting in increased accuracy are likely to remain key trends in the market.
ELISA Diagnostics Tests Market Analysis
The rising prevalence of infectious diseases among animals and increasing incidences of human infections are the major factors driving the market growth. According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals or environments account for 450,000 cases of illnesses, 5,000 hospitalizations, and 76 deaths among humans in the US alone. Additionally, as per a CDC report published in 2022, every year, 4 in 10 adults in the US have two or more diseases, with 6 in 10 adults having a chronic disease. Moreover, innovative product launches and recent developments in the market are expected to create lucrative opportunities for the ELISA diagnostics test market during 2022-2030.
ELISA Diagnostics Tests Market Overview
The rising prevalence of infectious disease among animals and increasing incidences of human infections are the major factors driving the market growth. North America accounts for the major market share closely followed by Europe. The US holds the major market share owing the increasing prevalence of infectious diseases among humans and animals leads to the increased use of ELISA diagnostics test followed by the new product launches by major market players headquartered in the country. Asia Pacific is anticipated to register a significant growth rate owing to the rising animal-associated infection to humans is a standalone factor responsible for the influential market growth in Asia Pacific region. China is one of the major countries where ecology poses a risk for emerging, re-emerging, and novel diseases that could threaten China and the Rest of world owing to the vast population of ~ 1.4 billion and 50% of the world’s livestock. However, The ELISA diagnostic test market in India is expected to flourish during the forecast period owing to increasing government funding, rising healthcare costs, and growing adoption of technologically advanced diagnostic equipment in healthcare organizations.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
ELISA Diagnostics Tests Market: Strategic Insights
Market Size Value in US$ 1,285.49 million in 2022 Market Size Value by US$ 2,271.23 million by 2030 Growth rate CAGR of 7.37% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
ELISA Diagnostics Tests Market: Strategic Insights
| Market Size Value in | US$ 1,285.49 million in 2022 |
| Market Size Value by | US$ 2,271.23 million by 2030 |
| Growth rate | CAGR of 7.37% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
ELISA Diagnostics Tests Market Drivers and Opportunities
Increasing incidence of Human infections to Favor Market
According to the CDC report published in 2022, every year, 4 in 10 adults in the US have two or more diseases, with 6 in 10 adults having a chronic disease. Among the chronic diseases, over 1.7 million cancer diagnoses are conducted, and nearly 600,000 cancer deaths are recorded every year in the US. Additionally, more than 34 million people in the US (10.5%) have diabetes, with 88 million adults (more than 1 in 3) having prediabetes, resulting in an increase in the risk of suffering from type 2 diabetes. The healthcare expenditure on death and disability due to chronic diseases accounts for US$ 4.1 trillion annually in the US alone.
In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world resulting in market growth during the forecast period.
Recent Developments in the Market Create Lucrative Opportunities
ELISA is one of the most widely used immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Additionally, the low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits increase the demand for human and animal research led to the new product launches in the market. For instance, in June 2022, EUROIMMUN launched two CE marked assays – the Anti-SARS-CoV-2 RBD ChLIA (IgG) and the Anti-SARS-CoV-2 Omicron ELISA (IgG). Both test systems enable the detection of IgG antibodies formed against SARS-CoV-2 and are available to laboratories in countries that accept the CE mark. Additionally, in May 2022, Agdia, Inc. commercialized its assays for detection of Rhizoctonia solani on ELISA and ImmunoStrip platforms.
ELISA Diagnostics Tests Market Report Segmentation Analysis
Key segments that contributed to the derivation of the ELISA diagnostics tests market analysis are adoption, test type, application, and end user.
- Based on adoption, the ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.
- By test type, the market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest share of the market in 2022.
- In terms of application, the market is segmented into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held a significant share of the market in 2022.
- Based on end user, the market is classified into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held a significant share of the market in 2023.
ELISA Diagnostics Tests Market Share Analysis by Geography
The geographic scope of the ELISA diagnostics tests market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market owing to the rising infectious diseases among humans, acting as a standalone factor positively influencing the growth of the market. Additionally, technological advancements in ELISA diagnostic kits further enhance the overall market growth during 2022-2030. The US accounts for the major market share owing to the rising incidences of infectious diseases among humans due to high zoonotic disease cases boosting the adoption of ELISA diagnostic tests in the US. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
ELISA Diagnostics Tests Market Report Scope
ELISA Diagnostics Tests Market News and Recent Developments
The ELISA diagnostics tests market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the ELISA diagnostics tests market are listed below:
- Charles River Laboratories International, Inc. launched its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. (Source: Charles River, Company Website, February 2023)
- Neogen Corporation launched its innovative Veratox VIP assay for the detection of walnut, the third assay in Neogen's Veratox VIP line of enhanced quantitative ELISA products. (Source: Neogen Corporation, Press Release, November 2023)
- Quest Diagnostics has been granted breakthrough device designation from the U.S. Food and Drug Administration (FDA) for AAVrh74 ELISA assay (CDx). (Source: Quest Diagnostics, Newsletter, September 2023)
ELISA Diagnostics Tests Market Report Coverage and Deliverables
The “ELISA Diagnostics Tests Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- ELISA diagnostics tests market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- ELISA diagnostics tests market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- ELISA diagnostics tests market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the ELISA diagnostics tests market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Adoption, Test Type, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The expected CAGR of the ELISA diagnostics tests market is 7.64%
The estimated value of the ELISA diagnostics tests market by 2031 is US$ 2.46 Bn.
Advancements in ELISA-Based Procedures results for increased accuracy are the future trends of the ELISA diagnostics tests market
The leading players operating in the ELISA diagnostics tests market includes Bio-Rad Laboratories Inc, Idexx Laboratories Inc, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corp, Innovative Diagnostics , Pictor Ltd, DiaSorin SpA, Elabscience Biotechnology Inc, Bio-Techne Corporation, among others
Rising Infectious Diseases Among Animals and Increasing Incidence of Human Infections are the driving factors impacting the ELISA diagnostics tests market
North America region dominated the ELISA diagnostics tests market in 2023
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to ELISA Diagnostics Tests Market
Nov 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Nov 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Nov 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2023
Bioreactors Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization), and Geography
Nov 2023
Poultry Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography
Nov 2023
ELISA Diagnostics Tests Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography
Nov 2023
Direct-To-Consumer Genetic Testing Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography
Nov 2023
Transient Protein Expression Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)